Clinical Trials on Human Papilloma Virus Infection Type 6 in Sweden

Total 104 results

Vastra Gotaland Region

Completed

Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI.

Infertility, Male | Human Papilloma Virus

Sweden
Karolinska Institutet

Recruiting

HPV-based Screening Among Women 23-29 Years of Age

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papilloma Virus

Sweden
Lund University
Swedish Cancer Society

Completed

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection

Sweden
Karolinska Institutet

Enrolling by invitation

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection (NPA-DC)

RSV Infection | SARS CoV 2 Infection | Influenza B Virus Infection | Influenza A Infection

Sweden
Tripep AB
Inovio Pharmaceuticals

Unknown

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Chronic Hepatitis C Virus Infection

Sweden
Uppsala University
Center for Clinical Research Dalarna, Sweden

Completed

The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome

Sepsis | Corona Virus Infection | ARDS, Human

Sweden
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection

Hepatitis C Virus Infection

Russian Federation, Sweden
Göteborg University
The Swedish Research Council; Roche Pharma AG

Completed

Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 (RibaC)

Hepatitis C

Sweden
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Influenza, Human

Sweden
Region Örebro County
University of Cambridge; Örebro University, Sweden; The Swedish Heart and Lung...

Recruiting

Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE (ELIMINATE)

Cardiovascular Diseases | Inflammatory Response | Acute Myocardial Infarction

Sweden
GlaxoSmithKline

Completed

Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

Influenza

Sweden
Karolinska Institutet
Merck Sharp & Dohme LLC

Enrolling by invitation

Education, Immigration and HPV Vaccination: an Informational Randomized Trial

Cervical Cancer | Vulvar Cancer | Head Cancer | Neck Cancer | Genital Wart | Anus Cancer | Penis Cancer | Mouse Papilloma

Sweden
Karolinska Institutet
The Swedish Research Council; Hoffmann-La Roche

Completed

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment (DICO)

Chronic Hepatitis C | Human Immunodeficiency Virus

Sweden
Karolinska Institutet
AbbVie

Completed

Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response (HEPCASUS)

Hepatocellular Carcinoma | Hepatitis C

Sweden
Örebro University, Sweden

Active, not recruiting

Cardiac Injury in Patients With Influenza

Myocardial Injury | Influenza, Human

Sweden
NORDynamIC Study Group

Completed

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Hepatitis C Virus

Sweden
Sahlgrenska University Hospital, Sweden

Completed

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

Organ Transplantation

Sweden
Sahlgrenska University Hospital, Sweden

Unknown

Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.

Organ Transplantation

Sweden
GlaxoSmithKline

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

Hepatitis B

Belgium, Canada, Sweden
Göteborg University
Sahlgrenska University Hospital, Sweden

Not yet recruiting

Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B (STOP-B)

Hepatitis B, Chronic

Sweden
Karolinska University Hospital
Karolinska Institutet

Withdrawn

Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively

Hepatitis B | Hepatitis A | Tuberculosis | Cystic Fibrosis

Sweden
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Influenza

Sweden, Netherlands
Göteborg University
Hoffmann-La Roche

Terminated

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin (RelapC)

Chronic Hepatitis C

Sweden
Helsinki University Central Hospital

Unknown

PCV13 + Hepatitis A Vaccine for Adults (PCV13+HepA)

Measurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis A

Finland, Sweden
Karolinska University Hospital

Recruiting

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients (SEE-D)

Chronic Hepatitis D

Sweden
GlaxoSmithKline

Completed

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Sweden, Norway
ChronTech Pharma AB
Inovio Pharmaceuticals

Unknown

CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Chronic Hepatitis C

Sweden
GlaxoSmithKline

Completed

Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults

Haemophilus Influenzae | Streptococcus Pneumoniae

Sweden
Sormland County Council, Sweden

Unknown

Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Vaccine Response Impaired

Sweden
Karolinska Institutet
Karolinska University Hospital

Completed

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Glioblastoma Multiforme | Cytomegalovirus Infection

Sweden
Swedish Institute for Infectious Disease Control

Unknown

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease (Sero 2007)

Hepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type B

Sweden
Janssen-Cilag International NV

Completed

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment (PROTEA)

Human Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) Virus

France, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland
Region Skane

Completed

Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy

Hepatitis C

Sweden
Suzhou Ribo Life Science Co. Ltd.

Recruiting

A Study of RBD1016 in CHB Participants

Chronic Hepatitis b

Sweden
Göteborg University
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; Skane... and other collaborators

Completed

Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C (TTG1)

Chronic Hepatitis C, Genotype 1

Sweden
GlaxoSmithKline

Terminated

Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza

Virus Diseases

United States, Sweden, Russian Federation, Romania
Lars Rombo

Completed

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Response to Hepatitis A Vaccine

Finland, Sweden
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

HIV Infections | Infection, Human Immunodeficiency Virus

Germany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
ViiV Healthcare
Janssen Research and Development

Completed

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Human Immunodeficiency Virus Type 1 (HIV-1)

Germany, Spain, United States, Italy, Canada, Argentina, Sweden
Tibotec Pharmaceuticals, Ireland

Completed

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

HIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1

United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
Merck Sharp & Dohme LLC

Completed

Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)

HCV Infection

United States, Germany, Poland, Sweden
Janssen R&D Ireland

Completed

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

Human Immunodeficiency Virus Type 1

United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
Oslo University Hospital
Karolinska University Hospital; Hvidovre University Hospital; Addis Ababa University and other collaborators

Completed

The Norwegian Nucleoside Analogue Stop Study (Nuc-Stop)

Hepatitis B, Chronic

Norway, Denmark, Ethiopia, Sweden
Karolinska University Hospital

Completed

Prevalence of Influenza RelAted Invasive Aspergillosis (PIRAIA)

Influenza, Human | Invasive Pulmonary Aspergillosis

Sweden
Tibotec BVBA

Completed

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Hepatitis C, Chronic

France, United Kingdom, Sweden
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

Influenza

Germany, Sweden, Netherlands
NextCell Pharma Ab
Karolinska Trial Alliance

Recruiting

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Influenza A | Respiratory Syncytial Virus (RSV) | COVID-19 Acute Respiratory Distress Syndrome | Metapneumovirus Pneumonia

Sweden
Boehringer Ingelheim

Withdrawn

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Hepatitis C, Chronic

Australia, Spain, Sweden
Region Stockholm
Karolinska Institutet

Completed

Cardiac Dysfunction in Critically Ill Covid-19 Patients

COVID-19 | Pulmonary Hypertension | Right Ventricular Dysfunction | ARDS, Human | Left Ventricular Dysfunction | Cardiac Failure

Sweden
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

Influenza

Germany, Sweden, Netherlands

Clinical Trials on Human Papilloma Virus Infection Type 6 in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations